Literature DB >> 21618356

Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: a poly-A purification solution.

T A Kerr1, M A Ciorba, H Matsumoto, V R T Davis, J Luo, S Kennedy, Y Xie, A Shaker, B K Dieckgraefe, N O Davidson.   

Abstract

BACKGROUND: Dextran sulfate sodium (DSS) induces experimental colitis and promotes colitis-associated cancer in rodents. Here we document potent inhibition of real-time quantitative polymerase chain reaction (qPCR) using cDNA from DSS-exposed mouse tissues, which complicates gene expression analysis.
METHODS: We characterize DSS inhibition of qPCR in-vitro and in a wide array of murine tissues following ingestion of DSS. We examine different approaches to RNA purification prior to cDNA synthesis in order to optimize real-time polymerase chain reaction amplification and gene expression analysis.
RESULTS: DSS inhibits qPCR amplification of cDNA between 1 and 10 nM. Orally administered DSS interferes with qPCR amplification of cDNA derived from multiple tissues. Poly-A purification of DSS-exposed RNA allows reliable and cost-effective gene expression analysis in DSS-exposed tissue.
CONCLUSIONS: DSS is a potent inhibitor of real-time qPCR amplification and interferes with tissue-specific gene expression analysis in DSS-exposed mice. Poly-A purification of tissue-derived RNA results in reliable and cost-effective gene expression analysis in DSS-exposed mice.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618356      PMCID: PMC3600644          DOI: 10.1002/ibd.21763

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  The effects of plant polysaccharides and buffer additives on PCR.

Authors:  T Demeke; R P Adams
Journal:  Biotechniques       Date:  1992-03       Impact factor: 1.993

2.  Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.

Authors:  Rikako Suzuki; Hiroyuki Kohno; Shigeyuki Sugie; Hitoshi Nakagama; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2005-08-04       Impact factor: 4.944

3.  MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model.

Authors:  Caitlyn W Barrett; Barbara Fingleton; Amanda Williams; Wei Ning; Melissa A Fischer; Mary K Washington; Rupesh Chaturvedi; Keith T Wilson; Scott W Hiebert; Christopher S Williams
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

4.  cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation.

Authors:  Eric Albert; John Walker; Aducio Thiesen; Thomas Churchill; Karen Madsen
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

5.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

6.  Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response.

Authors:  Katharina Brandl; Sophie Rutschmann; Xiaohong Li; Xin Du; Nengming Xiao; Bernd Schnabl; David A Brenner; Bruce Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 7.  Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.

Authors:  Mayumi Kawada; Atsuko Arihiro; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

8.  XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.

Authors:  Arthur Kaser; Ann-Hwee Lee; Andre Franke; Jonathan N Glickman; Sebastian Zeissig; Herbert Tilg; Edward E S Nieuwenhuis; Darren E Higgins; Stefan Schreiber; Laurie H Glimcher; Richard S Blumberg
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

9.  Differential susceptibilities of DNA polymerases-alpha and -beta to polyanions.

Authors:  T Shimada; M Yamada; M Miwa; H Nagano; Y Mano
Journal:  Nucleic Acids Res       Date:  1978-09       Impact factor: 16.971

10.  Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.

Authors:  Masayuki Fukata; Anli Chen; Arunan S Vamadevan; Jason Cohen; Keith Breglio; Suneeta Krishnareddy; David Hsu; Ruliang Xu; Noam Harpaz; Andrew J Dannenberg; Kotha Subbaramaiah; Harry S Cooper; Steven H Itzkowitz; Maria T Abreu
Journal:  Gastroenterology       Date:  2007-09-14       Impact factor: 22.682

View more
  22 in total

1.  Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).

Authors:  Ameet I Thaker; Anisa Shaker; M Suprada Rao; Matthew A Ciorba
Journal:  J Vis Exp       Date:  2012-09-11       Impact factor: 1.355

2.  Characterization of Colorectal Cancer Development in Apc (min/+) Mice.

Authors:  ILKe Nalbantoglu; Valerie Blanc; Nicholas O Davidson
Journal:  Methods Mol Biol       Date:  2016

3.  RNA Purity, Real-Time PCR Sensitivity, and Colon Segment Influence mRNA Relative Expression in Murine Dextran Sodium Sulfate Experimental Colitis.

Authors:  Bernardo Oldak; Mayra Cruz-Rivera; Ana Flisser; Fela Mendlovic
Journal:  J Biomol Tech       Date:  2018-07-13

4.  Autotaxin loss accelerates intestinal inflammation by suppressing TLR4-mediated immune responses.

Authors:  Su Jin Kim; Cody Howe; Jonathon Mitchell; Jieun Choo; Alexandra Powers; Angelos Oikonomopoulos; Charalabos Pothoulakis; Daniel W Hommes; Eunok Im; Sang Hoon Rhee
Journal:  EMBO Rep       Date:  2020-09-01       Impact factor: 8.807

5.  Calprotectin protects against experimental colonic inflammation in mice.

Authors:  Carlos J Aranda; Borja Ocón; María Arredondo-Amador; María Dolores Suárez; Antonio Zarzuelo; Walter J Chazin; Olga Martínez-Augustin; Fermín Sánchez de Medina
Journal:  Br J Pharmacol       Date:  2018-09-02       Impact factor: 8.739

6.  Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease.

Authors:  Shrey Kanvinde; Yashpal Singh Chhonker; Rizwan Ahmad; Fei Yu; Richard Sleightholm; Weimin Tang; Lee Jaramillo; Yi Chen; Yuri Sheinin; Jing Li; Daryl J Murry; Amar B Singh; David Oupický
Journal:  Acta Biomater       Date:  2018-10-17       Impact factor: 8.947

7.  Myeloid cells protect intestinal epithelial barrier integrity through the angiogenin/plexin-B2 axis.

Authors:  Rongpan Bai; Desen Sun; Muxiong Chen; Xiaoliang Shi; Liang Luo; Zhengrong Yao; Yaxin Liu; Xiaolong Ge; Xiangwei Gao; Guo-Fu Hu; Wei Zhou; Jinghao Sheng; Zhengping Xu
Journal:  EMBO J       Date:  2020-06-08       Impact factor: 11.598

8.  IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.

Authors:  Ameet I Thaker; M Suprada Rao; Kumar S Bishnupuri; Thomas A Kerr; Lynne Foster; Jeffrey M Marinshaw; Rodney D Newberry; William F Stenson; Matthew A Ciorba
Journal:  Gastroenterology       Date:  2013-05-10       Impact factor: 22.682

9.  Purification of Total RNA from DSS-treated Murine Tissue via Lithium Chloride Precipitation.

Authors:  Emilie Viennois; Anika Tahsin; Didier Merlin
Journal:  Bio Protoc       Date:  2018-05-05

10.  Examination of the Anti-Inflammatory, Antioxidant, and Xenobiotic-Inducing Potential of Broccoli Extract and Various Essential Oils during a Mild DSS-Induced Colitis in Rats.

Authors:  Kristin Mueller; Nicole Michaela Blum; Andreas Stefan Mueller
Journal:  ISRN Gastroenterol       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.